Skip to content

British Journal of Pain

ISSN 2049-4637, 2049-4645

5 papers in the library · 34 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers.

British Journal of Pain September 4, 2025 Mauro Cavarra, Nadia R. P. W. Hutten, Jan Schepers et al.

Background: Preliminary research indicates that psychedelics may hold promise as analgesic agents. This study investigated the potential analgesic effects of lysergic acid diethylamide (LSD) microdosing on pain tolerance and subjective pain perception in healthy participants. Methods: Utilizing a randomised, placebo-controlled design, participants received 15 μg of LSD or placebo over four...

Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use

British Journal of Pain February 11, 2025 Anne Baker, Stephanie Lake, Philippe Lucas et al. 7 citations

Psychedelic substances have shown preliminary efficacy for several neuropsychiatric disorders and are currently being investigated for chronic pain conditions. However, few studies have investigated outcomes of naturalistic psychedelic use among individuals with chronic pain, and none have assessed psychedelic-related changes in substance use patterns in this population. In a cross-sectional...

Experience of compassion-based practice in mindfulness for health for individuals with persistent pain.

British Journal of Pain February 23, 2024 Callum Gray, Fergal Jones, Alessio Agostinis et al. 1 citation

Purpose of the Study: Research indicates that acquiring compassion is an integral part to positive outcomes to Mindfulness-based interventions (MBI), yet there is both theoretic and empirical literature suggesting that people with persistent pain are more likely to experience challenges and distress when engaging compassion-based practices. Mindfulness for Health is a standardised MBI for...

Practicing self-hypnosis to reduce chronic pain: A qualitative exploratory study of HYlaDO.

British Journal of Pain February 2024 Rémi Caron-Trahan, Anne-Eva Jusseaux, Maryse Aubin et al.

Background: Nearly a quarter of Canada's population suffers from chronic pain, a long-lasting medical condition marked by physical pain and psychological suffering. Opioids are the primary treatment for pain management in this condition; yet, this approach involves several undesirable side effects. In contrast to this established approach, non-pharmacological interventions, such as medical...

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.

British Journal of Pain July 14, 2022 Valerie Bonnelle, Will J Smith, Natasha L. Mason et al. 26 citations

Although several studies and reports have shown the potential analgesic use of serotonergic psychedelics in cancer pain, phantom limb pain and cluster headache, evidence supporting their use for chronic pain is still limited. The past years have seen a considerable renewal of interest toward the therapeutic use of these compounds for mood disorders, resulting in a marked increase in the number...

DOI: 10.1177/20494637221114962 (opens in new tab) Full text (opens in new tab) Psychedelics: classical psychedelics Hallucinogens Entheogens Psychotropics +9